Page 7 - Biosolution Baltimore News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article NEW YORK, April 23, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. ("Emergent" or "the Company") (NYSE: EBS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Emergent securities between July 6, 2020 and March 31, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/ebs. This class action seeks...

NEW YORK, NY / ACCESSWIRE / April 23, 2021 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Emergent BioSolutions Inc. (NYSE:EBS) between July 6, 2020 through March 31, 2021, inclusive (the "Class Period").

Credit: Phil Yacuboski The surprise shortage of doses of Johnson & Johnson's COVID-19 vaccine is expected to persist, Gov. Larry Hogan said Friday. "The reduction we saw... that that's going to continue likely for another couple of weeks," Hogan said at a news conference. "The good news is we did 82,000 shots yesterday. We have the ability to do 100,000 or more as soon as they can get us those vaccines." The slowdown, however, will mean Maryland will receive 250,000 fewer doses from the federal governm...

POLITICO Get the Prescription Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by Gilead Sciences, Inc. With Emily Martin and Dan Goldberg On Tap — Michigan lawmakers want Biden to send extra vaccine doses to the hard-hit state. — The Congressional Budget Office takes a deep dive on pharmaceutical R&D.

Presented by With Dan Goldberg, Rachel Roubein and Alice Miranda Ollstein Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Quick Fix — Federal health officials knew about problems at a vaccine plant well before it ruined 15 million doses of Johnson & Johnson vaccine. — Billions of dollars in new funding is arriving too late for the many contact tracing pro...